330 related articles for article (PubMed ID: 35328833)
1. Endometrial Cancer Stem Cells: Where Do We Stand and Where Should We Go?
Banz-Jansen C; Helweg LP; Kaltschmidt B
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328833
[TBL] [Abstract][Full Text] [Related]
2. The Diminishment of Novel Endometrial Carcinoma-Derived Stem-like Cells by Targeting Mitochondrial Bioenergetics and MYC.
Helweg LP; Windmöller BA; Burghardt L; Storm J; Förster C; Wethkamp N; Wilkens L; Kaltschmidt B; Banz-Jansen C; Kaltschmidt C
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269569
[TBL] [Abstract][Full Text] [Related]
3. Sorafenib targets and inhibits the oncogenic properties of endometrial cancer stem cells via the RAF/ERK pathway.
Takao T; Masuda H; Kajitani T; Miki F; Miyazaki K; Yoshimasa Y; Katakura S; Tomisato S; Uchida S; Uchida H; Tanaka M; Maruyama T
Stem Cell Res Ther; 2022 Jun; 13(1):225. PubMed ID: 35659728
[TBL] [Abstract][Full Text] [Related]
4. Targeting cancer stem cell signature gene SMOC-2 Overcomes chemoresistance and inhibits cell proliferation of endometrial carcinoma.
Lu H; Ju DD; Yang GD; Zhu LY; Yang XM; Li J; Song WW; Wang JH; Zhang CC; Zhang ZG; Zhang R
EBioMedicine; 2019 Feb; 40():276-289. PubMed ID: 30594556
[TBL] [Abstract][Full Text] [Related]
5. Dual-specificity phosphatase 6 plays a critical role in the maintenance of a cancer stem-like cell phenotype in human endometrial cancer.
Kato M; Onoyama I; Yoshida S; Cui L; Kawamura K; Kodama K; Hori E; Matsumura Y; Yagi H; Asanoma K; Yahata H; Itakura A; Takeda S; Kato K
Int J Cancer; 2020 Oct; 147(7):1987-1999. PubMed ID: 32159851
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of PD-L1 in endometrial cancer stem-like cells is regulated by hypoxia.
Yin S; Guo Y; Wen X; Zeng H; Chen G
Front Biosci (Landmark Ed); 2022 Jan; 27(1):23. PubMed ID: 35090328
[TBL] [Abstract][Full Text] [Related]
7. Stem cell programs in cancer initiation, progression, and therapy resistance.
Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
[TBL] [Abstract][Full Text] [Related]
8. EXOSC5 maintains cancer stem cell activity in endometrial cancer by regulating the NTN4/integrin β1 signalling axis.
Huang YH; Wang WL; Wang PH; Lee HT; Chang WW
Int J Biol Sci; 2024; 20(1):265-279. PubMed ID: 38164180
[TBL] [Abstract][Full Text] [Related]
9. Insluin and epithelial growth factor (EGF) promote programmed death ligand 1(PD-L1) production and transport in colon cancer stem cells.
Chen M; Sharma A; Lin Y; Wu Y; He Q; Gu Y; Xu ZP; Monteiro M; Gu W
BMC Cancer; 2019 Feb; 19(1):153. PubMed ID: 30770752
[TBL] [Abstract][Full Text] [Related]
10. The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer.
Dong P; Konno Y; Watari H; Hosaka M; Noguchi M; Sakuragi N
J Transl Med; 2014 Aug; 12():231. PubMed ID: 25141911
[TBL] [Abstract][Full Text] [Related]
11. Constitutive activation of signal transducer and activator of transcription 3 (STAT3) and nuclear factor κB signaling in glioblastoma cancer stem cells regulates the Notch pathway.
Garner JM; Fan M; Yang CH; Du Z; Sims M; Davidoff AM; Pfeffer LM
J Biol Chem; 2013 Sep; 288(36):26167-26176. PubMed ID: 23902772
[TBL] [Abstract][Full Text] [Related]
12. Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
Safa AR
Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972
[TBL] [Abstract][Full Text] [Related]
13. SPARC was overexpressed in human endometrial cancer stem-like cells and promoted migration activity.
Yusuf N; Inagaki T; Kusunoki S; Okabe H; Yamada I; Matsumoto A; Terao Y; Takeda S; Kato K
Gynecol Oncol; 2014 Aug; 134(2):356-63. PubMed ID: 24769035
[TBL] [Abstract][Full Text] [Related]
14. Targeting LIN28B reprograms tumor glucose metabolism and acidic microenvironment to suppress cancer stemness and metastasis.
Chen C; Bai L; Cao F; Wang S; He H; Song M; Chen H; Liu Y; Guo J; Si Q; Pan Y; Zhu R; Chuang TH; Xiang R; Luo Y
Oncogene; 2019 Jun; 38(23):4527-4539. PubMed ID: 30742065
[TBL] [Abstract][Full Text] [Related]
15. PD-L1 Expression on Lung Cancer Stem Cells in Metastatic Lymph Nodes Aspirates.
Raniszewska A; Polubiec-Kownacka M; Rutkowska E; Domagala-Kulawik J
Stem Cell Rev Rep; 2019 Apr; 15(2):324-330. PubMed ID: 30397852
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma.
Dai X; Guo Y; Hu Y; Bao X; Zhu X; Fu Q; Zhang H; Tong Z; Liu L; Zheng Y; Zhao P; Fang W
Theranostics; 2021; 11(7):3489-3501. PubMed ID: 33537099
[TBL] [Abstract][Full Text] [Related]
17. Addiction to the IGF2-ID1-IGF2 circuit for maintenance of the breast cancer stem-like cells.
Tominaga K; Shimamura T; Kimura N; Murayama T; Matsubara D; Kanauchi H; Niida A; Shimizu S; Nishioka K; Tsuji EI; Yano M; Sugano S; Shimono Y; Ishii H; Saya H; Mori M; Akashi K; Tada KI; Ogawa T; Tojo A; Miyano S; Gotoh N
Oncogene; 2017 Mar; 36(9):1276-1286. PubMed ID: 27546618
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy: A Potential Approach to Targeting Cancer Stem Cells.
Wang W; Bai L; Xu D; Li W; Cui J
Curr Cancer Drug Targets; 2021; 21(2):117-131. PubMed ID: 32364076
[TBL] [Abstract][Full Text] [Related]
19. MiR-491 attenuates cancer stem cells-like properties of hepatocellular carcinoma by inhibition of GIT-1/NF-κB-mediated EMT.
Yang X; Ye J; Yan H; Tang Z; Shen J; Zhang J; Yang L
Tumour Biol; 2016 Jan; 37(1):201-9. PubMed ID: 26188902
[TBL] [Abstract][Full Text] [Related]
20. [PD-L1-Mediated Immune Escape Mechanism of Cancer Stem-Like Cells].
Matsuki M; Hirohashi Y; Torigoe T
Gan To Kagaku Ryoho; 2019 May; 46(5):850-854. PubMed ID: 31189802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
